BG106229A - Заместени пуринови производни като инхибитори на клетъчна адхезия - Google Patents

Заместени пуринови производни като инхибитори на клетъчна адхезия Download PDF

Info

Publication number
BG106229A
BG106229A BG106229A BG10622901A BG106229A BG 106229 A BG106229 A BG 106229A BG 106229 A BG106229 A BG 106229A BG 10622901 A BG10622901 A BG 10622901A BG 106229 A BG106229 A BG 106229A
Authority
BG
Bulgaria
Prior art keywords
alkyl
aryl
alkoxy
group
cycloalkyl
Prior art date
Application number
BG106229A
Other languages
Bulgarian (bg)
English (en)
Inventor
Anuschirwan Peyman
Jochen Knolle
Thomas Gadek
Jean-Francois Gourvest
Jean-Marie Ruxer
Original Assignee
Aventis Pharma Deutschland Gmbh
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh, Genentech, Inc. filed Critical Aventis Pharma Deutschland Gmbh
Publication of BG106229A publication Critical patent/BG106229A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG106229A 1999-07-02 2001-12-17 Заместени пуринови производни като инхибитори на клетъчна адхезия BG106229A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99112637A EP1065208A1 (en) 1999-07-02 1999-07-02 Substituted purine derivatives as inhibitors of cell adhesion
PCT/EP2000/005921 WO2001002399A1 (en) 1999-07-02 2000-06-26 Substituted purine derivatives as inhibitors of cell adhesion

Publications (1)

Publication Number Publication Date
BG106229A true BG106229A (bg) 2002-08-30

Family

ID=8238483

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106229A BG106229A (bg) 1999-07-02 2001-12-17 Заместени пуринови производни като инхибитори на клетъчна адхезия

Country Status (30)

Country Link
US (1) US6747016B1 (xx)
EP (2) EP1065208A1 (xx)
JP (1) JP2003503497A (xx)
KR (1) KR20020015997A (xx)
CN (1) CN1171888C (xx)
AR (1) AR034242A1 (xx)
AT (1) ATE262528T1 (xx)
AU (1) AU774382B2 (xx)
BG (1) BG106229A (xx)
BR (1) BR0012050A (xx)
CA (1) CA2376673A1 (xx)
CZ (1) CZ20014553A3 (xx)
DE (1) DE60009296T2 (xx)
EA (1) EA005372B1 (xx)
EE (1) EE200100713A (xx)
ES (1) ES2219353T3 (xx)
HU (1) HUP0300183A3 (xx)
IL (1) IL147245A0 (xx)
MX (1) MXPA01013241A (xx)
MY (1) MY122631A (xx)
NO (1) NO20016403L (xx)
NZ (1) NZ516095A (xx)
PL (1) PL352281A1 (xx)
SK (1) SK18792001A3 (xx)
TR (1) TR200103858T2 (xx)
TW (1) TWI229080B (xx)
UA (1) UA72923C2 (xx)
WO (1) WO2001002399A1 (xx)
YU (1) YU89701A (xx)
ZA (1) ZA200200017B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042655A1 (de) 2000-08-31 2002-03-14 Aventis Pharma Gmbh Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
FR2847254B1 (fr) 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
FR2870541B1 (fr) 2004-05-18 2006-07-14 Proskelia Sas Derives de pyrimidines antigonistes du recepteur de la vitronectine
WO2007089335A2 (en) * 2005-12-29 2007-08-09 Lexicon Pharmaceutical Inc. Multicyclic amino acid derivatives and methods of their use
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN107450106A (zh) * 2017-09-28 2017-12-08 北京小米移动软件有限公司 饮水安全提示方法、装置及智能水杯
US11691963B2 (en) 2020-05-06 2023-07-04 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
EP4267574A1 (en) 2020-12-23 2023-11-01 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
US11970494B2 (en) 2021-11-09 2024-04-30 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10501222A (ja) * 1994-05-27 1998-02-03 メルク エンド カンパニー インコーポレーテッド 破骨細胞仲介骨吸収を抑制するための化合物
EP0934305A4 (en) * 1996-08-29 2001-04-11 Merck & Co Inc INTEGRINE ANTAGONISTS
WO1998018461A1 (en) * 1996-10-30 1998-05-07 Merck & Co., Inc. Integrin antagonists
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
WO1998031359A1 (en) * 1997-01-17 1998-07-23 Merck & Co., Inc. Integrin antagonists
JP2002501054A (ja) * 1998-01-23 2002-01-15 アヴェンティス ファルマ ドイチェラント ゲーエムベーハー 骨吸収の阻害剤として及び細胞接着の阻害剤としての新規のスルホンアミド誘導体
AU2610099A (en) 1998-01-28 1999-08-16 Danmist Aps Method of piezoelectrically atomising and pumping fluids and piezoelectric fluidatomising and pumping device

Also Published As

Publication number Publication date
CN1171888C (zh) 2004-10-20
AR034242A1 (es) 2004-02-18
MY122631A (en) 2006-04-29
KR20020015997A (ko) 2002-03-02
IL147245A0 (en) 2002-08-14
PL352281A1 (en) 2003-08-11
HUP0300183A2 (hu) 2003-06-28
SK18792001A3 (sk) 2002-07-02
TWI229080B (en) 2005-03-11
WO2001002399A1 (en) 2001-01-11
EE200100713A (et) 2003-04-15
HUP0300183A3 (en) 2005-12-28
ZA200200017B (en) 2003-01-02
DE60009296D1 (de) 2004-04-29
YU89701A (sh) 2004-09-03
NO20016403D0 (no) 2001-12-28
TR200103858T2 (tr) 2002-06-21
EP1065208A1 (en) 2001-01-03
ATE262528T1 (de) 2004-04-15
AU5534900A (en) 2001-01-22
DE60009296T2 (de) 2005-05-25
CZ20014553A3 (cs) 2002-06-12
NO20016403L (no) 2002-03-01
CA2376673A1 (en) 2001-01-11
BR0012050A (pt) 2002-12-31
EP1196416A1 (en) 2002-04-17
NZ516095A (en) 2004-08-27
AU774382B2 (en) 2004-06-24
EA005372B1 (ru) 2005-02-24
EP1196416B1 (en) 2004-03-24
EA200200121A1 (ru) 2002-06-27
JP2003503497A (ja) 2003-01-28
US6747016B1 (en) 2004-06-08
CN1371376A (zh) 2002-09-25
UA72923C2 (uk) 2005-05-16
MXPA01013241A (es) 2002-06-21
ES2219353T3 (es) 2004-12-01

Similar Documents

Publication Publication Date Title
JP2002501054A (ja) 骨吸収の阻害剤として及び細胞接着の阻害剤としての新規のスルホンアミド誘導体
JP4642242B2 (ja) 細胞接着の阻害剤としての新規のグアニジン誘導体
BG106229A (bg) Заместени пуринови производни като инхибитори на клетъчна адхезия
EP1210348B1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
US6762190B2 (en) Thienylalanine derivatives as inhibitors of cell adhesion
US7259159B2 (en) Guanidino derivatives as inhibitors of cell adhesion